UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 255

Sortiert nach

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients

Neoplasia (New York, N.Y.), 2017-10, Vol.19 (10), p.848-855

2017

Volltextzugriff (PDF)

Nanoparticles for drug delivery in cancer treatment

Urologic oncology, 2008, Vol.26 (1), p.57-64

2008

Volltextzugriff (PDF)

Microchip-based immunomagnetic detection of circulating tumor cells

Lab on a chip, 2011-10, Vol.11 (20), p.3449-3457

2011

Volltextzugriff (PDF)

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

Neurology, 2011-01, Vol.76 (1), p.87

2011

Volltextzugriff (PDF)

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset

Blood, 2013-04, Vol.121 (14), p.2669

2013

Volltextzugriff (PDF)

Versatile Immunomagnetic Nanocarrier Platform for Capturing Cancer Cells

ACS nano, 2013-10, Vol.7 (10), p.8816-8823

2013

Volltextzugriff (PDF)

Circulating Tumor Cells in Patients with Breast Cancer Dormancy

Clinical cancer research, 2004-12, Vol.10 (24), p.8152-8162

2004

Volltextzugriff (PDF)

Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost

PloS one, 2016-05, Vol.11 (5), p.e0155326-e0155326

2016

Volltextzugriff (PDF)

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL

Neurology, 2013-07, Vol.81 (3), p.256

2013

Volltextzugriff (PDF)

HER-2 Gene Amplification Can Be Acquired as Breast Cancer Progresses

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (25), p.9393-9398

2004

Volltextzugriff (PDF)

Aberrant Promoter Methylation Profile of Prostate Cancers and Its Relationship to Clinicopathological Features

Clinical cancer research, 2002-02, Vol.8 (2), p.514-519

2002

Volltextzugriff (PDF)

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Molecular cancer research, 2015-04, Vol.13 (4), p.784-794

2015

Volltextzugriff (PDF)

Preclinical antitumor activity of S‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

Cancer science, 2014-08, Vol.105 (8), p.1040-1048

2014

Volltextzugriff (PDF)

Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system

Biomedical microdevices, 2013-08, Vol.15 (4), p.673-681

2013

Volltextzugriff (PDF)

Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines

Journal of thoracic oncology, 2009-02, Vol.4 (2), p.161-166

2009

Volltextzugriff (PDF)

uPAR and HER-2 Gene Status in Individual Breast Cancer Cells from Blood and Tissues

Proceedings of the National Academy of Sciences - PNAS, 2006-11, Vol.103 (46), p.17361-17365

2006

Volltextzugriff (PDF)

Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]

Cancer letters, 2015-04, Vol.360 (1), p.87-87

2015

Volltextzugriff (PDF)

Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference

Clinical cancer research, 2003-03, Vol.9 (3), p.931-946

2003

Volltextzugriff (PDF)

Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (18), p.7448-7456

2008

Volltextzugriff (PDF)

Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit

Clinical cancer research, 2004-05, Vol.10 (10), p.3333-3341

2004

Volltextzugriff (PDF)

Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Urologic oncology, 2015-01, Vol.33 (1), p.23.e9-23.e14

2015

Volltextzugriff (PDF)

PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6673-6678

2004

Volltextzugriff (PDF)

Inactivation of Cyclin D2 Gene in Prostate Cancers by Aberrant Promoter Methylation

Clinical cancer research, 2003-10, Vol.9 (13), p.4730-4734

2003

Volltextzugriff (PDF)

Molecular profiling of individual tumor cells by hyperspectral microscopic imaging

Translational research : the journal of laboratory and clinical medicine, 2012-05, Vol.159 (5), p.366-375

2012

Volltextzugriff (PDF)

Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer

Cancer letters, 2006-10, Vol.242 (2), p.222-230

2006

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Englisch
(255)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients

Nanoparticles for drug delivery in cancer treatment

Microchip-based immunomagnetic detection of circulating tumor cells

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset

Versatile Immunomagnetic Nanocarrier Platform for Capturing Cancer Cells

Circulating Tumor Cells in Patients with Breast Cancer Dormancy

Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL

HER-2 Gene Amplification Can Be Acquired as Breast Cancer Progresses

Aberrant Promoter Methylation Profile of Prostate Cancers and Its Relationship to Clinicopathological Features

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Preclinical antitumor activity of S‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system

Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines

uPAR and HER-2 Gene Status in Individual Breast Cancer Cells from Blood and Tissues

Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]

Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference

Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene

Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit

Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma

PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates

Inactivation of Cyclin D2 Gene in Prostate Cancers by Aberrant Promoter Methylation

Molecular profiling of individual tumor cells by hyperspectral microscopic imaging

Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer

Suchergebnisse filtern